Dihexa

Also known as: N-hexanoic-Tyr-Ile-(6) aminohexanoic amide

CognitivePRECLINICAL

Clinical Status

Preclinical — Research compound.

Mechanism of Action

Activates hepatocyte growth factor signaling through the c-Met receptor. Promotes dendritic spine formation, enhances synaptic connections, and supports neuronal survival.

Dosing Defaults

Dose

5-20 mg

Frequency

1x daily

Administration

Oral, sublingual, or intranasal

Timing

Morning

Food

with or without

Duration

2-4 week cycles

Dose range: 5-40 mg daily

Morning dosing supports cognitive function throughout the day.

Side Effects

•Nervousness
•Headache
•Anxiety
•Insomnia
•Nausea
•Concerns about tumor development

Contraindications & Warnings

•Not medical advice
•NO human clinical trials

Compare

Compare Dihexa with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your Dihexa dose.

Open Calculator

Related Cognitive Peptides

Selank

PHASE 2

Cognitive

Anxiolytic peptide approved in Russia. Non-sedative, non-addictive.

Semax

PHASE 2

Cognitive

Nootropic peptide approved in Russia. Enhances focus, memory, and neuroplasticity.

Noopept

PHASE 2

Cognitive

Dipeptide-derived nootropic for memory and neuroprotection. Approved in Russia.

P21

PRECLINICAL

Cognitive

Neurogenic peptide that promotes hippocampal neurogenesis in research models.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.